Article

Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of…

Oxidative Medicine and Cellular Longevity · 2018 · Donato Cappetta, author Loreta Pia Ciuffreda, author Anna Cozzolino, author Grazia Esposito, author Cristina Scavone, author Luigi Sapio, author Silvio Naviglio, author Domenico D’Amario, author Filippo Crea, author Francesco Rossi, author Liberato Berrino, author Antonella De Angelis, author Konrad Urbanek, author Laura Sartiani, Guest Editor

Key facts

Title Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension
First author Donato Cappetta, author Loreta Pia Ciuffreda, author Anna Cozzolino, author Grazia Esposito, author Cristina Scavone, author Luigi Sapio, author Silvio Naviglio, author Domenico D’Amario, author Filippo Crea, author Francesco Rossi, author Liberato Berrino, author Antonella De Angelis, author Konrad Urbanek, author Laura Sartiani, Guest Editor
Journal Oxidative Medicine and Cellular Longevity
Published Aug 2, 2018
DOI 10.1155/2019/8912768
Devices mentioned K011853, K990017, K990149, K990150, K990161, K990162, K990282, K990391, K990394, K990424, K990587, K990610
Product codes mentioned CDQ, DHR, JJX, JJY

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature